SUBSCRIPTIONS |
|
DTCNews Subscription
|
|
|
|
We accept |
|
|
|
|
|
Vacacionar Travel S.A. use Credit du Nord as a guarantee of absolute security in credit card transactions. |
|
|
|
|
|
|
|
|
|
|
|
:
|
|
|
|
|
|
|
|
|
|
|
|
Vaccine Trials on Cuba-US Agenda |
|
|
Monday, March 20, 2017
Havana.- Experts from Cuba and the United States team up in the phase of clinical trials of vaccines developed by the island against lung cancer.
At the end of last year, investigations were authorized with the therapeutic vaccine CIMAVAX EGF and the monoclonal antibody Nimotuzumab, both with registries in several countries.
In US, researchers from the Roswell Park Institute of New York are interested in the benefits of both formulas to extend the survival of patients and quality of life.
The trials will also seek to demonstrate the safety of Cuban compounds in combination with another molecule recently registered in the US.
The studies, with about 100 patients each, will test the interaction with Nivolumab, second line therapy for patients with recurrent lung cancer.
|
|
|
|
|
|
|
|